Suven Pharmaceuticals Limited (SUVENPHAR.BO)
INR 1149.5
(9.3%)
INR 1149.5
(9.3%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.6 Billion INR | -34.48% |
| 2022 | 5.36 Billion INR | -1.65% |
| 2021 | 5.45 Billion INR | 33.08% |
| 2020 | 4.09 Billion INR | 17.27% |
| 2019 | 3.49 Billion INR | 124.86% |
| 2018 | 1.55 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 665.3 Million INR | 68.26% |
| 2023 Q2 | 860.69 Million INR | -44.26% |
| 2023 Q4 | 560.97 Million INR | 7.07% |
| 2023 FY | 3.51 Billion INR | -34.48% |
| 2023 Q3 | 523.92 Million INR | -39.13% |
| 2023 Q1 | 1.54 Billion INR | -1.72% |
| 2022 Q3 | 1.34 Billion INR | 53.05% |
| 2022 Q1 | 1.39 Billion INR | -4.93% |
| 2022 FY | 5.36 Billion INR | -1.65% |
| 2022 Q4 | 1.57 Billion INR | 16.86% |
| 2022 Q2 | 878.48 Million INR | -36.97% |
| 2021 Q1 | 1.05 Billion INR | 23.71% |
| 2021 FY | 5.45 Billion INR | 33.08% |
| 2021 Q4 | 1.46 Billion INR | -16.47% |
| 2021 Q3 | 1.75 Billion INR | 55.88% |
| 2021 Q2 | 1.12 Billion INR | 6.61% |
| 2020 Q4 | 853.75 Million INR | -42.86% |
| 2020 Q3 | 1.49 Billion INR | 50.19% |
| 2020 Q2 | 994.79 Million INR | -17.51% |
| 2020 FY | 4.09 Billion INR | 17.27% |
| 2020 Q1 | 1.2 Billion INR | 29.04% |
| 2019 Q2 | 1.28 Billion INR | 10.4% |
| 2019 FY | 3.49 Billion INR | 124.86% |
| 2019 Q3 | 852.89 Million INR | -33.84% |
| 2019 Q4 | 934.48 Million INR | 9.57% |
| 2019 Q1 | 1.16 Billion INR | 1.33% |
| 2018 Q4 | 1.15 Billion INR | 160.79% |
| 2018 Q3 | 441.86 Million INR | 0.0% |
| 2018 FY | 1.55 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 95.582% |
| NATCO Pharma Limited | 25.96 Billion INR | 82.252% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -1748.596% |
| Achyut Healthcare Limited | 4.43 Million INR | -103722.51% |
| Ajanta Pharma Limited | 19.67 Billion INR | 76.584% |
| Alkem Laboratories Limited | 19.46 Billion INR | 76.325% |
| Alpa Laboratories Limited | 184.49 Million INR | -2397.408% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 19.98% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -168.276% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 89.082% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -274.301% |
| Brooks Laboratories Limited | 14.44 Million INR | -31808.885% |
| Divi's Laboratories Limited | 33.08 Billion INR | 86.071% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 93.197% |
| Eris Lifesciences Limited | 5.18 Billion INR | 11.079% |
| FDC Limited | 2.98 Billion INR | -54.297% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 29.139% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 48.685% |
| Granules India Limited | 6.81 Billion INR | 32.407% |
| Gufic Biosciences Limited | 1.32 Billion INR | -246.463% |
| Hester Biosciences Limited | 364.81 Million INR | -1163.025% |
| Indoco Remedies Limited | 1.29 Billion INR | -256.477% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -4.232% |
| Ipca Laboratories Limited | 7.98 Billion INR | 42.264% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -806.784% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 3132.202% |
| Lasa Supergenerics Limited | -458 Million INR | 1106.025% |
| Laurus Labs Limited | 3.94 Billion INR | -16.691% |
| Lupin Limited | 28.04 Billion INR | 83.57% |
| Mankind Pharma Limited | 21.51 Billion INR | 78.587% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 100.3 Million INR | -4493.861% |
| Megasoft Limited | -121.1 Million INR | 3904.699% |
| Piramal Pharma Limited | 4.55 Billion INR | -1.114% |
| RPG Life Sciences Limited | 2.29 Billion INR | -101.005% |
| Sigachi Industries Limited | 1.47 Billion INR | -212.617% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 211.971% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Wanbury Limited | 569.71 Million INR | -708.761% |
| Windlas Biotech Limited | 1.29 Billion INR | -254.737% |
| ZIM Laboratories Limited | 253.82 Million INR | -1715.255% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 89.311% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -65.386% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -907.038% |
| Bal Pharma Limited | 233.9 Million INR | -1869.844% |
| Strides Pharma Science Limited | 5.22 Billion INR | 11.829% |
| Venus Remedies Limited | 534.65 Million INR | -761.804% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -47.298% |
| Nectar Lifesciences Limited | 923.8 Million INR | -398.767% |
| Shilpa Medicare Limited | 1.36 Billion INR | -237.242% |
| Aarti Drugs Limited | 7.14 Billion INR | 35.546% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -188.555% |
| Suven Life Sciences Limited | -1.22 Billion INR | 475.882% |
| Ind-Swift Limited | 1.22 Billion INR | -275.838% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 67.74% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 219.589% |
| Themis Medicare Limited | 392.58 Million INR | -1073.656% |
| Hikal Limited | 32.11 Million INR | -14249.558% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 81.813% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -635.458% |
| Wockhardt Limited | -670 Million INR | 787.708% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 11.204% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -50708.197% |
| Neuland Laboratories Limited | 5.31 Billion INR | 13.359% |
| Morepen Laboratories Limited | 4.17 Billion INR | -10.394% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -2114.681% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -16680.694% |